ghk cu wikipedia GHK-Cu Research Peptide Australia Copper Peptides (GHK-Cu) for Skin:

Full COA posted on the product page

also labeled PNB-0408) is a synthetic oligopeptide derived from angiotensin IV, developed in the Harding and Wright labs at Washington State University and later commercialized through M3 Biotechnology and Athira Pharma

Standard reconstitution is 2mL of bacteriostatic water into the 80mg vial, giving a 40mg/mL concentration where each U-100 unit (0.01mL) delivers 0.4mg of total blend

Safety and Clinical Considerations Current clinical data regarding PDA (BPC-157-Arginine) remain limited

Afternoon Afternoon Those who engage in rigorous physical activities later on may find the afternoon as a favorable compromise for ingesting BPC-157